The risk of cardiovascular disease following breast cancer by Framingham risk score

被引:0
作者
Sofie A. M. Gernaat
Jolanda M. A. Boer
Desiree H. J. van den Bongard
Angela H. E. M. Maas
Carmen C. van der Pol
Rhodé M. Bijlsma
Diederick E. Grobbee
Helena M. Verkooijen
Petra H. Peeters
机构
[1] Utrecht University,Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
[2] Utrecht University,Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM)
[3] Utrecht University,Department of Radiation Oncology, University Medical Center Utrecht
[4] Radboud University Medical Center Nijmegen,Department of Cardiology
[5] Utrecht University,Department of Surgical Oncology
[6] Utrecht University,Department of Medical Oncology, University Medical Center Utrecht
[7] Utrecht University,Imaging Division, University Medical Center Utrecht
[8] School of Public Health,Department of Epidemiology and Biostatistics
[9] Imperial College,undefined
来源
Breast Cancer Research and Treatment | 2018年 / 170卷
关键词
Breast cancer; Cardiovascular disease; Mortality; Morbidity; Risk;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:119 / 127
页数:8
相关论文
共 164 条
[1]  
Ferlay J(2014)GLOBOCAN 2012 v1.1, Cancer incidence and mortality worldwide: IARC cancer base International Journal of Cancer 136 359-386
[2]  
Soerjomataram I(2016)Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study JAMA Oncology 3 524-548
[3]  
Ervik M(2015)Benefits and harms of breast cancer screening: A Systematic review JAMA 314 1615-1634
[4]  
Dikshit R(2005)Effect of screening and adjuvant therapy on mortality from breast cancer New England Journal of Medicine 353 1784-1792
[5]  
Eser S(2007)Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma Journal of Clinical Oncology 25 4952-4960
[6]  
Mathers C(2008)Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer Journal of the National Cancer Institute 100 252-260
[7]  
Rebelo M(2016)Cardiovascular disease mortality among breast cancer survivors Epidemiology 27 6-13
[8]  
Parkin DM(2011)Prognosis of patients with breast cancer: Causes of death and effects of time since diagnosis, age, and tumor characteristics Journal of Clinical Oncology 29 4014-4021
[9]  
Forman D(2014)Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials The Lancet 383 2127-2135
[10]  
Bray F(2011)Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden Radiotherapy and Oncology 100 167-175